logo-loader
viewCallitas Health Inc

Callitas Health strikes deal with pregnancy test maker to distribute its co-branded ToConceive gel

Callitas Health CEO James Thompson said the company’s fertility lubricant is a 'perfect co-branding fit' with e.p.t. home pregnancy test kits

A couple in bed
The Cincinnati-based health and wellness company’s ToConceive was developed by Dr Ronald Thompson, a well-known infertility specialist

Callitas Health Inc (CSE:LILY) (OTCMKTS:WKULF) announced Tuesday that it had cemented a new partnership with NFI Consumer Healthcare’s flagship e.p.t, over-the-counter pregnancy test kit brand.

The top brand established in 1977 introduced one of the first over-the-counter home pregnancy test kits in North America.

“ToConceive, our clinically proven fertility lubricant, is a perfect cobranding fit with e.p.t. pregnancy test kits, a category leader in the women’s OTC health market,” said Callitas Health CEO James Thompson. “e.p.t.’s brand recognition in the space will help our company build awareness for the fantastic impact ToConceive can have on couples trying to get pregnant.”

READ: Callitas Health banks on CannaStrips and OTC products while swinging for the fence with blockbuster drugs

Cincinnati-based health and wellness company Callitas Health’s ToConceive was developed by Thompson’s father, Dr Ronald Thompson, a well-known gynecologic surgeon and infertility specialist with nearly three dozen patents. It was based on the science behind the 2010 Nobel Prize in Medicine for in vitro fertilization (IVF) and sperm capacitation.

It's FDA-cleared and clinically proven to increase a woman’s own natural conception lubrication, called transudate.

The partnership between NFI and Callitas will include promotional opportunities in stores, product samples and new product inclusion at major food, drug and mass retailers in the US.

“After purchasing EPT in 2017, our group began working on potential line extensions for the brand that would emerge it from only being a pregnancy test brand to becoming part of the complete family planning process,” said Benjamin Blessing, executive vice president of sales and marketing at NFI Consumer Products.

“Developing a packaging concept that included the ToConceive product just made sense to us,” Blessing said. “This is a brand completely devoted to helping women fulfill their desire to become pregnant. We are pleased to have a product that may facilitate a long-anticipated and life-changing pregnancy.”

Contact Uttara Choudhury at [email protected]

Follow her on Twitter@UttaraProactive 

Quick facts: Callitas Health Inc

Price: 0.11 CAD

CSE:LILY
Market: CSE
Market Cap: $3.62 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Callitas Health Inc named herein, including the promotion by the Company of Callitas Health Inc in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Callitas Therapeutics signs LOI with Simply Wholeistic, updates on THC & CBD...

Callitas Therapeutics (CSE:LILY) (OTCQB:MPHMF) Vice President of Sales & Business Development Joshua Maurice tells Proactive Investors the pharma company has signed a letter of intent with Simply Wholeistic to manufacture  its CannaStrip products in the U.S. Maurice added that as...

on 25/4/19

2 min read